1
|
Vrethem M, Kvarnström M, Stenstam J, Cassel P, Gustafsson M, Landtblom AM, Ernerudh J. Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands. Mult Scler 2011; 18:669-73. [DOI: 10.1177/1352458511424903] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
Objective: Since there are clinical and genetic differences between MS patients with intrathecal oligoclonal bands (OCB+) in the cerebrospinal fluid (CSF) compared with those without (OCB−), the aim was to find out if OCB− patients showed a different pattern of cytokine immune activation compared with OCB+ patients. Methods: The study included 25 MS patients (10 OCB− and 15 OCB+) and 13 controls. A panel of cytokines was measured; IL-1β, IL-6, IL-8/CXCL8, IL-10, TNF and GM-CSF in serum, CSF and in supernatants from polyclonally stimulated blood mononuclear cells, where also levels of IL-12p40, IL-13, IL-15, IL-17 and IFN-γ were measured. The concentrations of soluble (s) VCAM-1 and sCD14 were measured in serum and CSF. Results: In general, there were no extensive differences in cytokine concentrations between the OCB− and OCB+ groups. Conclusion: OCB− MS patients do not seem to constitute a separate entity concerning inflammatory parameters measured as cytokine concentrations in CSF and blood.
Collapse
Affiliation(s)
- M Vrethem
- Department of Neurology, Division of Neuroscience, Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Sweden
- Clinical Neurophysiology, Division of Neuroscience, Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Sweden
| | - M Kvarnström
- Division of Inflammatory Medicine, Unit of Autoimmunity and Immune Regulation, Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Sweden
| | - J Stenstam
- Division of Inflammatory Medicine, Unit of Autoimmunity and Immune Regulation, Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Sweden
| | - P Cassel
- Division of Inflammatory Medicine, Unit of Autoimmunity and Immune Regulation, Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Sweden
| | - M Gustafsson
- Department of Neurology, Division of Neuroscience, Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Sweden
| | - AM Landtblom
- Department of Neurology, Division of Neuroscience, Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Sweden
- Neurology Unit, Motala General Hospital, Sweden
| | - J Ernerudh
- Department of Neurology, Division of Neuroscience, Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Sweden
- Division of Inflammatory Medicine, Unit of Autoimmunity and Immune Regulation, Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Sweden
| |
Collapse
|